We are live on ! Find out more
USNA icon

Usana Health Sciences

149 hedge funds and large institutions have $609M invested in Usana Health Sciences in 2016 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 14

6% more funds holding

Funds holding: 140149 (+9)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

12% less capital invested

Capital invested by funds: $693M → $609M (-$84.2M)

43.32% less ownership

Funds ownership: 84.1%40.78% (-43%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
149
Holders Change
+9
Holders Change %
+6.43%
% of All Funds
3.73%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
24
Increased
50
Reduced
50
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$99.9M +$2.2M +33,734 +2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$87.9M +$1.42M +21,852 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$56.2M -$1.4M -21,459 -2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$42M +$839K +12,883 +2%
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$34.9M -$1.05M -16,078 -3%
BFA
6
BlackRock Fund Advisors
California
$19.3M +$3.05M +46,875 +17%
Nordea Investment Management
7
Nordea Investment Management
Sweden
$18.6M +$257K +3,946 +1%
BIT
8
BlackRock Institutional Trust
California
$16.8M -$25K -384 -0.1%
TA
9
Teachers Advisors
New York
$13.3M +$2.25M +34,503 +19%
Morgan Stanley
10
Morgan Stanley
New York
$12.2M +$1.3M +19,962 +11%
State Street
11
State Street
Massachusetts
$11.7M +$262K +4,022 +2%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$11.5M +$752K +11,544 +7%
JIM
13
Jupiter Investment Management
United Kingdom
$11.1M
Northern Trust
14
Northern Trust
Illinois
$9.8M +$214K +3,279 +2%
MCM
15
Matarin Capital Management
New York
$8.97M +$70.5K +1,082 +0.7%
PFC
16
Phocas Financial Corp
California
$8.31M +$3.74M +57,468 +73%
Charles Schwab
17
Charles Schwab
California
$7.38M +$3.4M +52,198 +76%
Norges Bank
18
Norges Bank
Norway
$6.86M +$128K +1,960 +2%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$6.74M +$856K +13,145 +14%
William Blair Investment Management
20
William Blair Investment Management
Illinois
$6.32M -$113K -1,740 -2%
TCIM
21
TIAA CREF Investment Management
New York
$5.78M -$139K -2,128 -2%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$5.27M -$2.78M -42,638 -33%
HA
23
Hays Advisory
Tennessee
$4.87M -$1.49M -22,934 -22%
Deutsche Bank
24
Deutsche Bank
Germany
$4.53M -$4.52M -69,421 -48%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$4.49M +$893K +13,700 +23%

USNA Hedge Fund Activity: Q4 2016 in Review

149 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2016, worth a combined $609M — down 12% from $693M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new USNA positions and 14 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Phocas Financial Corp, adding an estimated $3.74M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $7.87M sold.

  • 149 institutional investors held Usana Health Sciences (USNA) as of Q4 2016, up from 140 in Q3 2016.
  • Funds reported $609M of Usana Health Sciences stock for Q4 2016, down 12% quarter-over-quarter.
  • 24 funds opened new Usana Health Sciences positions in Q4 2016 and 14 closed out, a net change of +10 holders.
  • The largest Usana Health Sciences buyer in Q4 2016 was Phocas Financial Corp, an estimated $3.74M added.
  • The largest Usana Health Sciences seller in Q4 2016 was Two Sigma Investments, an estimated $7.87M sold.

Based on aggregated 13F filings for Q4 2016.